NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies has acquired the exclusive rights to develop and market some nanopore technologies from Harvard University and collaborators at the University of California Santa Cruz and the National Institute of Standards and Technology, the company said today.
Oxford, UK-based Oxford Nanopore said it has agreed to support nanopore research at Harvard that could help to advance the field.
The technology Oxford Nanopore has licensed includes intellectual property that was developed by Harvard researchers Daniel Branton, George Church, and Jene Golovchenko; University of California Santa Cruz collaborators David Deamer and Mark Akeson; and John Kasianowicz at the National Institute of Standards and Technology.
The technology is complementary to previous research conducted by Oxford Nanopore Co-founder Hagan Bayley. According to the firm, Bayley “pioneered the field of nanopores as sensors of single molecules, with a specific focus on the identification of DNA bases.”
The company said this label-free nanopore technology could help to reduce the cost of DNA sequencing. It also could be useful in many genomics applications, medical diagnostic development and treatments, and other areas such as energy, defense, and agriculture research, said Oxford Nanopore.
Financial terms of the agreement were not released.